The Ethical Challenges of Antimicrobial Resistance for Nurse Practitioners by Oerther, Sarah & Oerther, Daniel B.
Missouri University of Science and Technology 
Scholars' Mine 
Civil, Architectural and Environmental 
Engineering Faculty Research & Creative Works 
Civil, Architectural and Environmental 
Engineering 
01 Jan 2020 
The Ethical Challenges of Antimicrobial Resistance for Nurse 
Practitioners 
Sarah Oerther 
Daniel B. Oerther 
Missouri University of Science and Technology, oertherd@mst.edu 
Follow this and additional works at: https://scholarsmine.mst.edu/civarc_enveng_facwork 
 Part of the Civil and Environmental Engineering Commons 
Recommended Citation 
S. Oerther and D. B. Oerther, "The Ethical Challenges of Antimicrobial Resistance for Nurse Practitioners," 
Nursing Open, Wiley-Blackwell Publishing Ltd, Jan 2020. 
The definitive version is available at https://doi.org/10.1002/nop2.453 
This Editorial is brought to you for free and open access by Scholars' Mine. It has been accepted for inclusion in 
Civil, Architectural and Environmental Engineering Faculty Research & Creative Works by an authorized 
administrator of Scholars' Mine. This work is protected by U. S. Copyright Law. Unauthorized use including 
reproduction for redistribution requires the permission of the copyright holder. For more information, please 
contact scholarsmine@mst.edu. 
Nursing Open. 2020;00:1–3.    |  1wileyonlinelibrary.com/journal/nop2
 
Received: 5 January 2020  |  Accepted: 7 January 2020
DOI: 10.1002/nop2.453  
E D I T O R I A L
The ethical challenges of antimicrobial resistance for Nurse 
practitioners
Antimicrobial resistance (AMR) is one of the most challenging world-
wide health threats facing modern medicine (Centers for Disease 
Control, 2018; Logan & Bonomo, 2016; World Health Organization, 
2018; Zerr et al., 2014). According to the World Health Organization 
(2018), when antimicrobial drugs are no longer effective at killing 
infections caused by bacteria, fungi, parasites and viruses, this is 
called AMR. AMR leads to drug-resistant infections (World Health 
Organization, 2018). Nurse practitioners need to be leaders in mit-
igating risks associated with antimicrobial use, including ethical 
dilemmas surrounding AMR (Centers for Disease Control, 2018; 
Logan & Bonomo, 2016; World Health Organization, 2018; Zerr et 
al., 2014). For instance, prescribing antimicrobial drugs represents 
an ethical dilemma for nurse practitioners, since the health needs 
of individual patients must to be balanced against preservation of 
effective antimicrobial therapies and concerns for long-term preven-
tion of AMR in communities (Basu & Garg, 2018; Johnstone, 2016).
1  | CURRENT CONSIDER ATIONS FOR 
PRIMARY C ARE NURSE PR AC TITIONERS
The prognosis of AMR is increased morbidity and mortality from un-
controlled growth of a microorganism that is resistant to one, or even 
all, available antimicrobial therapies (Centers for Disease Control, 
2018; Logan & Bonomo, 2016; World Health Organization, 2018; 
Zerr et al., 2014). In hospital environments, microorganisms that 
are resistant to antimicrobial therapies lead to persistent, pervasive 
nosocomial infections that may be highly contagious, nearly impos-
sible to treat and possibly lethal (Centers for Disease Control, 2018; 
World Health Organization, 2018; Zerr et al., 2014). To provide qual-
ity care for patients with AMR, three practices are critical (Centers 
for Disease Control, 2018; Logan & Bonomo, 2016; World Health 
Organization, 2018; Zerr et al., 2014). First, hospitals and outpatient 
clinical facilities must be (re)designed to prevent the spread of no-
socomial infections. Second, additional rapid bedside diagnostics 
are required to evaluate antimicrobial susceptibility in real-time as 
part of the decision-making process in prescribing an antimicrobial 
therapy. Third, more expensive, last-line-of-defence antimicrobials 
will need to be reserved for longer inpatient treatment scenarios 
(Centers for Disease Control, 2018; Logan & Bonomo, 2016; World 
Health Organization, 2018; Zerr et al., 2014).
In the long-term, the threat from a postantimicrobial therapy 
world is that today's relatively minor infections—including practically 
unavoidable exposures to microbes associated with labour and deliv-
ery—may once again contribute to increased morbidity and mortality 
in both developed and in developing countries (Centers for Disease 
Control, 2018; Logan & Bonomo, 2016; World Health Organization, 
2018; Zerr et al., 2014). In developed countries, unchecked AMR may 
impact surgery and chemotherapy because antibiotics used to treat 
infections may no longer be effective (Centers for Disease Control, 
2018; Logan & Bonomo, 2016; World Health Organization, 2018; Zerr 
et al., 2014). And in developing countries, unchecked AMR may also 
co-occur alongside and impact the incidence and prevalence of ex-
isting wide-spread infections such as HIV, malaria and tuberculosis 
(Centers for Disease Control, 2018; World Health Organization, 2018).
Currently, nurse practitioners are unable to easily and quickly 
screen and diagnose many types of AMR because specimens must 
be sent to a centralized diagnostic laboratory for evaluation of 
antimicrobial susceptibility that often takes several days of test-
ing (Mitsakakis, Kaman, Elshout, Specht, & Hays, 2018). Until 
better bedside diagnostics are available, one of the best means 
of preventing the spread of AMR by nurse practitioners may be 
accomplished through a thorough history and physical exam, 
and by screenings (Ball, Dains, Flynn, Solomon, & Stewart, 2019; 
Hersh, Jackson, & Hicks, 2013). For instance, final diagnosis of a 
viral upper respiratory illness can usually be made clinically with 
little or no laboratory testing needed (Ball et al., 2019; Hersh et 
al., 2013). However, if a pre-school age child exhibits a high fever 
with sudden onset, body aches and fatigue, a primary care pro-
vider might use other screenings to rule-out a specific alternative 
differential diagnosis, such as influenza A or B (Ball et al., 2019; 
Hersh et al., 2013). Conversely, if a child presents with a severe 
sore throat, without a cough or other upper respiratory symptoms, 
it may be appropriate to do a rapid strep test to rule-out group A 
streptococcus infection (Ball et al., 2019; Muthanna, Salim, Hamat, 
Shamsuddin, & Zakariah, 2018). Unfortunately, there is no test to 
diagnose an upper respiratory tract infection in an outpatient clin-
ical setting (Ball et al., 2019). Similarly, the diagnosis for bacterial 
sinusitis, acute otitis media or viral bronchitis must be made via 
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2  |     EDITORIAL
clinical examination, without the support of diagnostic testing 
(Ball et al., 2019).
2  | ETHIC S
AMR needs to be viewed by nurse practitioners not just as a 
primary care issue but also an ethical issue (Basu & Garg, 2018; 
Johnstone, 2016). Nurse practitioners face three ethical chal-
lenges associated with AMR. First, the nurse practitioner must 
identify the safest ways to protect and promote the individual 
patient's well-being in the face of the collective threat to human 
health represented by AMR. Second, the nurse practitioner must 
identify how best to respond to competing needs as the amount 
of AMR increases and the effectiveness of existing antimicrobial 
drugs continues to decrease. Third, the nurse practitioner must 
balance the moral interest of different people, including future 
generations, while deciding and justifying a course of action that 
“normally” would not be morally acceptable (e.g. refusing to pre-
scribe an antimicrobial therapy and relying upon the expectation 
that an infection is self limiting). These ethical questions also bring 
up important concerns about the sufficiency and suitability of 
current ethical frameworks to tackle concerns surrounding AMR 
(Basu & Garg, 2018; Johnstone, 2016).
An important distinctive feature of AMR is the collective and 
reciprocal vulnerability of all people both as the vectors and vic-
tims of AMR organisms (Basu & Garg, 2018; Johnstone, 2016). 
Nurse practitioners must advocate in healthcare institutions that 
patients are not just stand-alone discrete individuals—a balance 
must be found between the individual patient and the collective 
health of the community. For instance, some hospitals are try-
ing to stop the spread of AMR by encouraging healthcare pro-
viders to prescribe narrow-spectrum antibiotics while reserving 
broad-spectrum drugs for emergencies or last resort (Ellegård, 
Dietrichson, & Anell, 2017). Ellegård et al. (2017) examined pay 
for performance (P4P)—monetary incentives to reach pre-defined 
prescribing targets—as a way to influence prescribers’ choice of 
antibiotics. Data from eight Swedish healthcare authorities used 
the P4P model as a way to encourage prescribers to select nar-
row-spectrum antibiotics more often in the treatment of children 
with respiratory tract infections (Ellegård et al., 2017). They found 
P4P significantly increased the use of narrow-spectrum antibiotics 
(Ellegård et al., 2017).
Unfortunately, the combination of monetary incentives from 
some hospitals a few different countries and limited knowledge 
about prescription guidelines for antimicrobial therapies can con-
tribute to unethical prescribing practices (Basu & Garg, 2018; 
Johnstone, 2016). Additionally, monetary prescribing practices may 
violate ethical principles core to health care, including: beneficence, 
patient autonomy, non-maleficence and justice (Basu & Garg, 2018). 
This incentive system may contribute to violation in the ethical 
principle of justice, which requires fair distribution of limited re-
sources (Basu & Garg, 2018). A nurse practitioner with prescription 
authority, anticipating ineffectiveness of a narrow-spectrum antibi-
otic and concerned with the risk of prolonged sickness among influ-
ential patients, may elect to prescribe a broad-spectrum antibiotic to 
those whom they favour (Basu & Garg, 2018). While such differential 
treatment is unethical and could contribute to class bias, it is not be-
yond reason to foresee a perverse outcome arising from such a mon-
etary incentive with the quality of medical care distributed based 
upon the resources of patients (Basu & Garg, 2018; Johnstone, 
2016). Therefore, nurse practitioners need to be on-guard when 
well-intentioned policies to prevent AMR may lead to unanticipated 
outcomes of questionable ethical practice.
3  | CONCLUSION
AMR brings to the forefront ethical issue that requires a new 
way of thinking for nurse practitioners, not just about the nature 
of the ethical issues AMR raises, but about how to best address 
these moral dilemmas (Johnstone, 2016). The imperatives of tack-
ling the gaps in healthcare ethics related to AMR can no longer 
be ignored by nurse practitioners. New innovative systems and 
theoretical frameworks are urgently needed to address the moral 
issues raised by AMR (Basu & Garg, 2018; Johnstone, 2016). As 
the threat from AMR grows, innovative systems and theoretical 
frameworks will have a major influence on how the above ques-
tions are addressed. The answers to the above questions will have 
a major impact on the types of changes that eventually will need 
to be made to current standards of care. In a postantimicrobial 
era, these will describe what counts as “optimal care.” What fu-
ture standard of optimal care will look like is unclear. As a vital 
part of the primary care workforce, nurse practitioners need to 
start preparing now through collaborative inquiry and education 
for the ethical challenges that remain ahead in guaranteeing just, 
humane and socially responsible consideration to the management 
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